BioUtah News
-
Utah’s Life Sciences Community Takes Off at the 2026 Entrepreneur & Investor Summit
The 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit) served as a launchpad for innovation
-
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
-
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Launch Represents Significant Step to Broader Commercialization
-
RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox
RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox
-
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry
-
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
-
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization
-
ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
SALT LAKE CITY, February 26, 2026— ARUP Laboratories, a leader in diagnostic medicine and the largest nonprofit reference laboratory…
-
Startups Selected to Pitch at the 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit
Twelve rising startups have been selected to present their innovations to investors during the 2026 Entrepreneur & Investor…
-
RadSep’s Purification and Molecular Recognition Technology
RadSep, Inc., a subsidiary of IBC Advanced Technologies, Inc., provides state-of-the-art purification technology and novel chelators for medical…
-
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for…
-
Cytiva Sponsors Operational Excellence Case Study Competition
Cytiva Sponsors Operational Excellence Case Study Competition
-
Life Sciences Day on the Hill 2026 — Recap
Featuring exhibits from over 20 local companies, including medical device, diagnostics, and biotech companies.
-
Fluidx Embolic IDE Trial Results Accepted for Late-Breaking Presentation at the SIR Annual Meeting
First podium presentation of IDE Clinical Trial Data of Novel Embolic Device to Treat Cancer
-
Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay
Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA…
-
Owlet® Announces Strategic AI Partnership with webAI to Power the Next Generation of Personalized Infant Health and Sleep Insights
Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant…
-
Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies
Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies
-
Behavioral Health Assessment Using Vocal Biomarkers
Behavioral Health Assessment Using Vocal Biomarkers
-
Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West
Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West
-
Owlet’s First Baby Sleep Report Analyzes Data from Over 1.2 Million Owlet Monitored Babies
Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep…
-
PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics and Its Role in the Company’s Phase 3/Pivotal Clinical Trial
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease
-
SPARC Health Announces Second Cohort Applications, Building on Inaugural Program Success
SPARC Health, a collaborative effort between Park City Angels (PCA), BioUtah, BioHive, in partnership with Governor’s Office of…
-
SPARC Health, BioUtah Co-Host Shark Tank-Style Pitch Competition at 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit
Taking place on March 12, 2026, at the Hilton Salt Lake City Center, the competition provides early-stage healthcare…
-
JP Morgan Healthcare Conference Recap – Photo Gallery
Check out the photo gallery from the 2026 JP Morgan Healthcare conference in San Francisco.
-
Haemonetics to Acquire Vivasure Medical
The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.
-
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026
-
DiscGenics Treats First Patient in Phase 3 Clinical Trial of IDCT (Rebonuputemcel) for Symptomatic Mild-to-Moderate Lumbar Degenerative Disc Disease
DiscGenics Treats First Patient in Phase 3 Clinical Trial of IDCT (Rebonuputemcel) for Symptomatic Mild-to-Moderate Lumbar Degenerative Disc…
-
Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications
Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening…
-
Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment
Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment
-
World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professor, to advise the Company on…
-
Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing
Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing
-
SINTX 2025 Highlights
As we look back at 2025, we’re thankful for the progress our team and partners helped drive this…
-
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter…
-
Bloom Surgical: 2025 Year In Review
2025 marked a year of significant progress of reached milestones and successes for Bloom Surgical
-
Adam Barker, PhD, Named President and Chief Operations Officer of ARUP Reference Business Unit
A microbiologist, Adam Barker, PhD, was ARUP’s chief scientific officer and director of Research and Development before being…
-
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
The Australian patent represents the first patent granted for the Company’s new point-of-care testing platform.
-
Merit Medical’s Fred Lampropoulos Honored by Nasdaq
Merit Medical’s Fred Lampropoulos Honored by Nasdaq
-
Perimeter Solutions Announces Agreement to Acquire MMT for $685 Million
Perimeter Solutions Announces Agreement to Acquire MMT for $685 Million
-
Freyya Recognized at Transatlantic Angel Competition (TAAC8)
Freyya Recognized at Transatlantic Angel Competition (TAAC8)
-
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
